Health In Tech, Inc. (HIT) Fair Value 2026

HIT · Software - Application ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.1 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (17/100)

Quick Summary — As of 2026-10-07, Health In Tech, Inc. (HIT) trades at $0.81, versus a $0.61 median fair value across its 2 active models — 24.9% below the current price. QOC: 8.1/10. Value Trap Risk: 17/100 (SAFE). 2/13 models active.

Key Facts

Ticker
HIT
Price
$0.81
Quality Score
8.1/10
Value Trap Risk
17/100
Models Active
2/13
Last Updated
Strength: Quality Score of 8.1/10 indicates strong fundamentals
Risk: Majority of models suggest overvaluation

Is Health In Tech, Inc. (HIT) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Health In Tech, Inc. (HIT) appears overvalued as of : the median of 2 independent fair value estimates is $0.61, 24.9% below the current price of $0.81. Estimates range from $0.49 to $0.72. HIT scores 8.1/10 on fundamental quality and 17/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -20.1% versus its own 13-model consensus, across 3,777 rated companies as of 2026-10-07. HIT’s -24.9% gap is wider than that market norm, and the Software - Application sector median is -20.8%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Health In Tech, Inc. Stock in 2026? →

What Fair Value Does Each Model Give HIT?

2 Intrinsic Value Models vs. Current Price ($0.81)

Core Models (Unlocked)
Model Fair Value Upside
Relative · Medium Conviction
 $0.49 -39.2%
Relative · Low Conviction
 $0.72 -10.5%

All Models Active

All 2 models are displayed above.

What Is Health In Tech, Inc. (HIT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Health In Tech, Inc.'s intrinsic value is estimated at $0.61, suggesting the stock is overvalued at its current price of $0.81. With 2 out of 2 models flagging downside (-24.9% vs price), the market may be pricing in unsustainable growth.

What Do the Models Say About HIT?

2 of 13 models are currently active for HIT. All 2 active models suggest the stock trades above fair value. Taken together, their median fair value for HIT is $0.61 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does HIT Rank in Software - Application?

Among 261 Software - Application stocks, HIT ranks #69 by Quality of Company score. CirclFi's QOC score of 8.1/10 evaluates 32 fundamental signals. A score of 8.1 places HIT in the top tier.

See all Most Undervalued Software - Application Stocks →

Within the Software - Application space, Health In Tech, Inc. competes in an environment where gross margin profile often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is HIT a Value Trap?

CirclFi's Value Trap algorithm assigns HIT a score of 17/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Health In Tech, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Health In Tech, Inc.'s fundamental quality profile registers 8.1/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

Models cluster within a tight range (+28.7% spread), increasing conviction. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every HIT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across HIT's 2 active models, average confidence is 26%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Health In Tech, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Software - Application Stocks Should You Also Analyze?

11 related Software - Application stocks with 13-model coverage

NATLNCR Atleos CorporationQOC 8.1RNGRingCentral, Inc.QOC 8.1PERFPerfect Corp.QOC 8.1DAVEDave Inc.QOC 8.0SRADSportradar Group AGQOC 8.1GRNDGrindr Inc.QOC 8.0INLXIntellinetics, Inc.QOC 6.7FUSEFusemachines Inc.QOC 4.9PAYCPaycom Software, Inc.QOC 9.7ADSKAutodesk, Inc.QOC 9.9PTCPTC Inc.QOC 9.8

Read investment analysis: NATL · RNG · PERF · DAVE · SRAD · GRND · INLX · FUSE · PAYC · ADSK · PTC

Which Other Stocks Have a Similar Quality Score to HIT?

7 companies across all industries closest to HIT’s Quality of Company score of 8.1/10.

VNTVontier CorporationQOC 8.1JANLJanel CorporationQOC 8.1TREXTrex Company, Inc.QOC 8.1INFUInfuSystem Holdings, Inc.QOC 8.1TKRThe Timken CompanyQOC 8.1LIVNLivaNova PLCQOC 8.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: VNT · JANL · TREX · INFU · TKR · LIVN · NVDA

Where Does HIT Sit in CirclFi's Software - Application Rankings?

HIT is ranked against every other Software - Application stock CirclFi covers in each of these screens.

See all Software - Application stocks ranked →

What Else Do Investors Ask About Health In Tech, Inc.’s Valuation?

What is Health In Tech, Inc.'s intrinsic value in 2026?

CirclFi puts Health In Tech, Inc. (HIT)'s intrinsic value at $0.61 — the median of 2 independent model estimates as of 2026-10-07, ranging from $0.49 to $0.72. The Quality of Company score is 8.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is HIT overvalued or undervalued right now?

At $0.81, 0 of 2 active models suggest HIT may be undervalued, while 2 indicate potential overvaluation. The median of all 2 fair value estimates is $0.61, 24.9% below the current price of $0.81 — a consensus view that HIT is overvalued. The assessment depends on which methodology best fits Health In Tech, Inc.'s business model in Software - Application.

What does a Quality of Company score of 8.1 mean for HIT?

Health In Tech, Inc.'s QOC of 8.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on HIT?

CirclFi analyzes HIT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is HIT a value trap in 2026?

Health In Tech, Inc.'s Value Trap score is 17/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Health In Tech, Inc. (HIT) has a median fair value of $0.61 — 24.9% below the current price of $0.81 — as of 2026-10-07.” Source: circlfi.com/stock/HIT/ · Methodology
Primary sources for this HIT valuation
  • Financial statements: Health In Tech, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0002019505) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for HIT as of ; valuations recomputed .